Report
Jeremy Garnier

AFYREN : Unsurprising H1 2024 results – pending continuous production at first plant

>H1 revenues of € 1.4m, down 30% / EBIT of -€ 3.6m - AFYREN’s H1 2024 results, reported yesterday evening, were broadly in line with our estimates. Revenues dropped by 30% to € 1.4m, with two constituent elements: i/ income from patent licences and ceded to AFYREN NEOXY since December 2018 for € 0.7m (stable) and ii/ service contracts with AFYREN NEOXY, also for € 0.7m (down as a result of the ramp-up of teams on site). Opex is stable (€ 5m), giving EBIT of -€ 3.6m. ...
Underlying
Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Jeremy Garnier

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch